Validation of the rapid test Carestart™ G6PD among malaria vivax-infected subjects in the Brazilian Amazon

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 49, Issue 4, 2016, Pages 446-455

  Brito, Marcelo Augusto Mota ^a,b   Peixoto, Henry Maia ^c   de Almeida, Anne Cristine Gomes ^a,b   de Oliveira, Maria Regina Fernandes ^c,d   Romero, Gustavo Adolfo Sierra ^c,d   Moura Neto, José Pereira ^e   Singh, Nakul ^f   Monteiro, Wuelton Marcelo ^a,b   de Lacerda, Marcus Vinícius Guimarães ^b,g  

^a FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

^b UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^c UNIVERSITY OF BRASILIA   (Brazil)

^d Instituto de Avaliação de Tecnologias em Saúde IATS INCT CNPq   (Brazil)

^e FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Care start G6PD; Glucose 6 phosphate dehydrogenase deficiency; Malaria; Plasmodium vivax

Indexed keywords

GENOMIC DNA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME ACTIVITY; GENE MUTATION; GENOTYPE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MALARIA RAPID TEST; MALE; PARASITEMIA; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY; VALIDATION PROCESS; BLOOD; CHILD; DIAGNOSTIC KIT; ENDEMIC DISEASE; MIDDLE AGED; POINT OF CARE SYSTEM; REPRODUCIBILITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; ENDEMIC DISEASES; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84984996494     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0134-2016     Document Type: Article

References (44)

1. Authors no listed. PRIMAQUINE 15mg. for 14 days cures "high percentage". Public Health Rep 1952; 67:179-180. PMID: 14900348.
2. Authors no listed. ARMY giving primaquine treatment to all returning servicemen. Public Health Rep 1952; 67:178-179. PMID: 14900346.
3. th Congr):58. PMID: 18872928.
4. Peixoto HM, Brito MA, Romero GA, Monteiro WM, de Lacerda MV, de Oliveira MR. G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study. Malar J 2015; 14:126.
5. Ley B, Luter N, Espino FE, Devine A, Kalnoky M, Lubell Y, et al. The challenges of introducing routine G6PD testing into radical cure: a workshop report. Malar J 2015; 14:377.
6. Beutler E, Dern RJ, Alving AS. The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis. J Lab Clin Med 1954; 44:439-442.
7. Martin SK, Miller LH, Alling D, Okoye VC, Esan GJ, Osunkoya BO, et al. Severe malaria and glucose-6-phosphate-dehydrogenase deficiency: a reappraisal of the malaria/G-6-P.D. hypothesis. Lancet 1979; 1:524-526.
8. Orimadegun AE, Sodeinde O. Glucose-6-phosphate dehydrogenase status and severity of malarial anaemia in Nigerian children. J Infect Dev Ctries 2011; 5:792-798.
9. Monteiro WM, Moura-Neto JP, Recht J, Bassat Q, Lacerda MV. Fatal primaquine-induced hemolysis in a patient with Plasmodium vivax malaria and G6PD A(-) variant in the Brazilian Amazon. Clin Infect Dis 2016; 62:1188.
10. Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol 2013; 81:133-201.
11. Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, et al. Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J 2013; 12:418.
12. Minucci A, Giardina B, Zuppi C, Capoluongo E. Glucose-6-phosphate dehydrogenase laboratory assay: how, when, and why? IUBMB Life 2009; 61:27-34.
13. Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotypephenotype association. Blood Rev 2007; 21:267-283.
14. Pandolfi PP, Sonati F, Rivi R, Mason P, Grosveld F, Luzzatto L. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J 1995; 14:5209-5215.
15. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008; 371:64-74.
16. Lyon MF. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 1961; 190:372-373.
17. Peters AL, Van Noorden CJF. Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. J Histochem Cytochem 2009; 57:1003-1011.
18. Osorio L, Carter N, Arthur P, Bancone G, Gopalan S, Gupta SK, et al. Performance of Binax NOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects. Am J Trop Med Hyg 2015; 92:22-27.
19. Tinley KE, Loughlin AM, Jepson A, Barnett ED. Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg 2010; 82:210-214.
20. Adu-Gyasi D, Asante KP, Newton S, Dosoo D, Amoako S, Adjei G, et al. Evaluation of the diagnostic accuracy of CareStart G6PD deficiency rapid diagnostic test (RDT) in a malaria endemic area in Ghana, Africa. PloS one 2015; 10:e0125796.
21. Baird JK, Dewi M, Subekti D, Elyazar I, Satyagraha AW. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells. Transl Res 2015; 165:677-688.
22. Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, et al. Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PloS one 2011; 6:e28357.
23. LaRue N, Kahn M, Murray M, Leader BT, Bansil P, McGray S, et al. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg 2014; 91:854-861.
24. Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, et al. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia. PloS one 2014; 9:e116143.
25. Peixoto HM, Brito MA, Romero GA, Monteiro WM, de Lacerda MV, de Oliveira MR. G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study. Malar J 2015; 14:126.
26. Santana MS, de Lacerda MVG, Barbosa MGV, Alecrim WD, Alecrim MCG. Glucose-6-phosphate dehydrogenase deficiency in an endemic area for malaria in Manaus: a cross-sectional survey in the Brazilian Amazon. PloS one 2009; 4:e5259.
27. Al-Musawi BM, Al-Allawi N, Abdul-Majeed BA, Eissa AA, Jubrael JM, Hamamy H. Molecular characterization of glucose-6-phosphate dehydrogenase deficient variants in Baghdad city - Iraq. BMC Blood Disord 2012; 12:4.
28. Gandomani MG, Khatami SR, Nezhad SR, Daneshmand S, Mashayekhi A. Molecular identification of G6PD Chatham (G1003A) in Khuzestan province of Iran. J Genet 2011; 90:143-145.
29. Hirono A, Beutler E. Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(-). Proc Natl Acad Sci 1988; 85:3951-3954.
30. Pamba A, Richardson ND, Carter N, Duparc S, Premji Z, Tiono AB, et al. Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone. Blood 2012; 120:4123-4133.
31. Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J 2013; 12:391.
32. Barraviera BM, Meira DA, Machado PE, Curi, PR. Malaria in the municipality of Humaitá, State of Amazonas. XXI. Prevalence of glucose-6-phosphate dehydrogenase in a population sample and in patients with Plasmodium falciparum malaria. Rev Inst Med Trop S Paulo 1987; 29:374-380.
33. Khim N, Benedet C, Kim S, Kheng S, Siv S, Leang R, et al. G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients. Malar J 2013; 12:171.
34. Satyagraha AW, Sadhewa A, Baramuli V, Elvira R, Ridenour C, Elyazar I, et al. G6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malaria. PLoS Negl Trop Dis 2015; 9:e0003602.
35. Muller SA, Amoah SK, Meese S, Spranger J, Mockenhaupt FP. High prevalence of anaemia among African migrants in Germany persists after exclusion of iron deficiency and erythrocyte polymorphisms. Trop Med Int Health 2015; 20:1180-1189.
36. Tine RC, Ndiaye M, Hansson HH, Ndour CT, Faye B, Alifrangis M, et al. The association between malaria parasitaemia, erythrocyte polymorphisms, malnutrition and anaemia in children less than 10 years in Senegal: a case control study. BMC Res Notes 2012; 5:565.
37. Santana MS, Monteiro WM, Siqueira AM, Costa MF, Sampaio V, Lacerda MV, et al. Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon. Trans R Soc Trop Med Hyg 2013; 107:301-306.
38. Amoako N, Asante KP, Adjei G, Awandare GA, Bimi L, Owusu-Agyei S. Associations between red cell polymorphisms and Plasmodium falciparum infection in the middle belt of Ghana. PloS one 2014; 9:e112868.
39. Carter N, Pamba A, Duparc S, Waitumbi JN. Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials. Malar J 2011; 10:241.
40. May J, Meyer CG, Grossterlinden L, Ademowo OG, Mockenhaupt FP, Olumese PE, et al. Red cell glucose-6-phosphate dehydrogenase status and pyruvate kinase activity in a Nigerian population. Trop Med Int Health 2000; 5:119-123.
41. Mombo LE, Ntoumi F, Bisseye C, Ossari S, Lu CY, Nagel RL, et al. Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren. Am J Trop Med Hyg 2003; 68:186-190.
42. Dewasurendra RL, Rockett KA, Fernando SD, Carter R, Kwiatkowski DP, Karunaweera ND, et al. G6PD gene variants and its association with malaria in a Sri Lankan population. Malar J 2015; 14:93.
43. World Health Organization Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. Malar J 2012; 11:424.
44. Bancone G, Chu CS, Chowwiwat N, Somsakchaicharoen R, Wilaisrisak P, Charunwatthana P, et al. Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests. Am J Trop Med Hyg 2015; 92:818-824.